E-Book, Englisch, 383 Seiten
Sridhar Diagnostic and Therapeutic Procedures in Gastroenterology
1. Auflage 2011
ISBN: 978-1-59745-044-7
Verlag: Humana Press
Format: PDF
Kopierschutz: Adobe DRM (»Systemvoraussetzungen)
An Illustrated Guide
E-Book, Englisch, 383 Seiten
ISBN: 978-1-59745-044-7
Verlag: Humana Press
Format: PDF
Kopierschutz: Adobe DRM (»Systemvoraussetzungen)
Autoren/Hrsg.
Weitere Infos & Material
1;Diagnostic and Therapeutic Procedures in Gastroenterology;3
1.1;Dedication;5
1.2;Foreword;7
1.3;Preface;9
1.4;Contents;11
1.5;Contributors;13
1.6;1: Esophageal Strictures and Endoscopic Management;17
1.6.1;Introduction;17
1.6.2;Etiology of Esophageal Strictures;18
1.6.3;Diagnostic Work-up;18
1.6.4;Indications for Endoscopic Esophageal Dilation;19
1.6.5;Patient Preparation for Esophageal Dilation;19
1.6.6;Endoscopic Dilation Techniques;20
1.6.7;Complications of Esophageal Dilation;24
1.6.8;Alternative Management;24
1.6.9;Summary of Key Points;24
1.6.10;References;24
1.7;2: Endoscopic Management of Barrett’s Esophagus;26
1.7.1;Introduction;26
1.7.2;Endoscopy in Barrett’s Esophagus;27
1.7.3;Endoscopic Surveillance;28
1.7.3.1;BE Without Dysplasia;28
1.7.3.2;BE with LGD;28
1.7.3.3;BE with HGD;29
1.7.4;Advanced Endoscopic Imaging of Barrett’s Esophagus;29
1.7.4.1;High-Resolution/High-Definition/Magnification Endoscopy;30
1.7.4.2;Chromoendoscopy;30
1.7.4.3;Narrow Band Imaging;31
1.7.4.4;Autofluorescence Imaging;32
1.7.4.5;Confocal Laser Endomicroscopy;34
1.7.5;Endoscopic Therapy in Barrett’s Esophagus;35
1.7.5.1;Patient Group to Be Treated;35
1.7.5.1.1;Patients with LGD;35
1.7.5.1.2;Patients with HGD;35
1.7.5.2;Pre-endoscopic Therapy Work-up;37
1.7.5.2.1;Role of EUS;37
1.7.5.2.2;Diagnostic EMR;37
1.7.5.3;Eradication Therapies for BE;38
1.7.5.4;Photodynamic Therapy;39
1.7.5.5;Radiofrequency Ablation;39
1.7.5.6;Cryotherapy;40
1.7.5.7;Limitations of Ablative Therapies;41
1.7.5.8;Complications of Ablative Therapies;41
1.7.5.9;Endoscopic Mucosal Resection or Mucosectomy;42
1.7.5.9.1;Therapeutic EMR;42
1.7.5.10;Post-endoscopic Therapy BE Surveillance;44
1.7.6;References;44
1.8;3: Gastrointestinal Tract Stenting;48
1.8.1;Introduction;48
1.8.2;Esophageal Stent Placement;48
1.8.2.1;Indications;48
1.8.2.2;Contraindications;49
1.8.2.3;Technique;50
1.8.2.4;Complications;52
1.8.2.5;Postoperative Care;53
1.8.2.6;Outcomes;53
1.8.3;Benign Disease;55
1.8.3.1;Available Devices;55
1.8.4;Enteral Stent Placement;56
1.8.4.1;Indications;56
1.8.4.2;Contraindications;57
1.8.4.3;Technique;57
1.8.4.4;Complications;59
1.8.4.5;Postoperative Care;60
1.8.4.6;Clinical Efficacy;60
1.8.4.7;Available Devices;60
1.8.4.8;Alternative Treatments;61
1.8.5;Colonic Stenting;61
1.8.5.1;Indications;61
1.8.5.2;Contraindications;62
1.8.5.3;Procedure;62
1.8.5.4;Complications;63
1.8.5.5;Postoperative Care;63
1.8.5.6;Clinical Data;64
1.8.5.7;Available Devices;64
1.8.5.8;Alternative Procedures;65
1.8.6;References;65
1.9;4: Endoscopic Management of Nonvariceal Upper Gastrointestinal Bleeding;69
1.9.1;Introduction;69
1.9.2;Causes of UGIB;70
1.9.2.1;Initial Evaluation of Patients with UGI Bleeding;70
1.9.2.2;Anatomy of a Bleeding Ulcer;71
1.9.2.3;Timing of Endoscopy;71
1.9.2.4;ENDOSCOPIC THERAPY OF BLEEDING PEPTIC ULCERS;72
1.9.3;Patient Monitoring;72
1.9.4;Patient Position;73
1.9.4.1;Gastric Lavage;74
1.9.4.2;Endoscopic Treatment;74
1.9.5;Thermal Therapy;74
1.9.5.1;Electrothermocoagulation;74
1.9.5.2;The Technique;75
1.9.6;Nonelectrothermocoagulation;75
1.9.6.1;The Technique;76
1.9.7;Injection Therapy;76
1.9.7.1;Agents Used;76
1.9.7.2;Thrombin/Fibrin Glue;77
1.9.7.3;The Technique;77
1.9.8;Mechanical Clips;77
1.9.8.1;The Technique;79
1.9.9;Choice of Techniques;79
1.9.9.1;Forrest Class Ia and Ib (Actively Bleeding Ulcers);81
1.9.9.2;Forrest Class IIa (Ulcer with Nonbleeding Visible Vessel);81
1.9.9.3;Forrest Class IIb (Ulcer with Adherent Clot);81
1.9.9.4;Post-endoscopic Therapy;82
1.9.9.5;Mallory–Weiss Tears;83
1.9.9.6;Second-Look Endoscopy;83
1.9.10;Conclusions;83
1.9.11;References;84
1.10;5: Endoscopic Management of Varices and Variceal Hemorrhage;86
1.10.1;Introduction;86
1.10.2;Risk Assessment of Patients;87
1.10.2.1;Primary Prophylaxis;88
1.10.2.2;Secondary Prophylaxis;90
1.10.3;Initial Management of Acute Variceal Hemorrhage;90
1.10.4;Endoscopic Variceal Band Ligation;93
1.10.4.1;Technique;93
1.10.4.2;Injection Therapy;95
1.10.4.3;Technique;95
1.10.4.4;Intravariceal Injection;96
1.10.4.5;Paravariceal Injection;97
1.10.5;Combination of Band Ligation and Sclerotherapy;98
1.10.5.1;Argon Plasma Coagulation;98
1.10.5.2;Gastric Varices;98
1.10.5.3;Follow-up;101
1.10.6;References;101
1.11;6: Argon Plasma Coagulation;104
1.11.1;Introduction;104
1.11.2;Indications;104
1.11.2.1;Hemostasis;105
1.11.2.2;Ablation;105
1.11.3;Contraindications;106
1.11.4;Procedure Description;106
1.11.4.1;The Plasma Coagulator Device;106
1.11.4.2;The Circuit: Monopolar Versus Bipolar;106
1.11.4.3;Mechanics;107
1.11.4.4;First- and Second-Generation APCs;108
1.11.4.5;Technique;109
1.11.5;Complications;109
1.11.5.1;Minor Complications;109
1.11.5.2;Major Complications;110
1.11.6;Postoperative Care;110
1.11.7;Alternative Procedures;110
1.11.8;Costs;111
1.11.8.1;Summary of Key Points;111
1.11.9;References;112
1.12;7: Endoscopic Mucosal Resection;113
1.12.1;Introduction;113
1.12.2;Indications;114
1.12.3;Defining the Lateral Margins of the Lesion;114
1.12.4;Determining the Depth of Tumor Invasion;116
1.12.5;Endoscopic Appearances;116
1.12.6;Endoscopic Ultrasound;117
1.12.7;Contraindications;117
1.12.8;Procedure Description;118
1.12.8.1;Define the Margins of the Lesion for Resection;118
1.12.8.2;Submucosal Injection;118
1.12.8.3;Resection Techniques;118
1.12.8.3.1;Injection-Assisted EMR;118
1.12.8.3.2;Cap-Assisted EMR;118
1.12.8.3.3;Ligation-Assisted EMR;119
1.12.8.4;Retrieval of Resected Lesion;121
1.12.8.5;Complications;121
1.12.8.6;Postoperative Care;122
1.12.9;Results;122
1.12.9.1;Esophagus;122
1.12.9.1.1;Squamous Cell Carcinoma;122
1.12.9.1.2;Barrett’s Esophagus with High-Grade Dysplasia and Early Cancer;122
1.12.9.2;Stomach;122
1.12.9.3;Colorectum;123
1.12.10;Alternative Procedures;123
1.12.10.1;Cost;124
1.12.11;Conclusions;124
1.12.11.1;Summary of Key Points;124
1.12.12;References;125
1.13;8: Enteral Nutrition: From Formulations to Delivery;128
1.13.1;Enteral Feeding Formulas;129
1.13.1.1;Standard Formulas;129
1.13.1.2;Fiber Containing Formulas;131
1.13.1.3;High Protein Formulas;131
1.13.1.4;Peptide-Based Formulas;131
1.13.1.5;Elemental Formulas;131
1.13.1.6;Disease Specific;131
1.13.2;Enteral Formula Delivery Methods;133
1.13.3;Monitoring Tube Feeding;134
1.13.3.1;Gastrointestinal Tolerance;134
1.13.3.1.1;Nausea and Vomiting;135
1.13.3.1.2;Gastric Residual Volume;136
1.13.3.2;Diarrhea;137
1.13.3.2.1;Bloating and Distention;138
1.13.3.3;Determination of Adequate Gut Function;139
1.13.4;Summary of Key Points;140
1.13.5;References;140
1.14;9: Capsule Endoscopy;142
1.14.1;Introduction;142
1.14.1.1;Box 1Limitations of all VCE;144
1.14.1.2;Obscure GI Bleeding;144
1.14.1.3;Box 2Small bowel VCE indications;144
1.14.1.4;Small Bowel Tumors;149
1.14.1.5;Crohn’s Disease;151
1.14.1.6;Celiac Disease;153
1.14.2;Contraindications;154
1.14.3;Box 3Small bowel VCE contraindications;154
1.14.4;Equipment;154
1.14.5;Technique;157
1.14.6;Box 4Small bowel VCE technique;157
1.14.7;Reading;158
1.14.8;Outcomes;158
1.14.9;Problems;160
1.14.10;Box 5 Small bowel VCE problems;161
1.14.11;Overcoming the Problems;162
1.14.12;Esophageal VCE;164
1.14.12.1;Introduction;164
1.14.12.2;Indications;164
1.14.12.2.1;Box 6 Esophageal VCE indications;164
1.14.12.2.2;Gastroesophageal Reflux and Barrett’s Esophagus;165
1.14.13;Contraindications;169
1.14.14;Box 7Esophageal VCE contraindications;169
1.14.15;Technique;169
1.14.16;Box 8Esophageal VCE technique;170
1.14.17;Colon VCE;170
1.14.18;Box 9 Review;171
1.14.19;Box 10Indications for VCE;171
1.14.20;Box 11 Relative contraindications and solutions;172
1.14.21;Box 12VCE procedure checklist;172
1.14.22;Summary of Key Points;172
1.14.23;References;172
1.15;10: Double Balloon Enteroscopy;175
1.15.1;Introduction;175
1.15.2;Principle of DBE;176
1.15.3;Device Description;176
1.15.4;Preprocedure Preparation;178
1.15.4.1;Sedation;178
1.15.5;Procedure;178
1.15.6;Route of Insertion;180
1.15.7;Indications;180
1.15.7.1;Diagnosis;180
1.15.7.2;Therapeutic;180
1.15.7.3;Salvage Therapy;180
1.15.8;Contraindications;182
1.15.9;Disadvantages;183
1.15.10;Complications;184
1.15.11;Alternative Procedures;184
1.15.11.1;Wireless Video Capsule Endoscopy;184
1.15.11.2;Enteroscopy;185
1.15.11.2.1;Single Balloon Enteroscopy;185
1.15.11.2.2;Spiral Enteroscopy;185
1.15.11.2.3;Push-Enteroscopy;186
1.15.11.2.4;Intraoperative Enteroscopy;186
1.15.11.3;Small Bowel Series;186
1.15.12;Costs;187
1.15.13;References;187
1.16;11: Sphincterotomy and Stents in Benign and Malignant Disorders and Biliary ERCP;192
1.16.1;Introduction;192
1.16.2;Sphincterotomy;192
1.16.3;Bile Duct Stenting;195
1.16.4;Pancreatic Duct Sphincterotomy and Stents;197
1.16.5;Cystgastrostomy;198
1.16.6;References;201
1.17;12: The Use of SpyGlass Direct Visualization System in the Management of Pancreato Biliary Disease;203
1.17.1;Introduction;203
1.17.2;Procedure Description;205
1.17.3;Indications;206
1.17.3.1;Diagnostic Indications;206
1.17.3.2;Therapeutic Indications;209
1.17.4;Contraindications;211
1.17.5;Complications and Safety;211
1.17.6;Post-Procedure Care;212
1.17.7;Comparative Procedures;212
1.17.8;Cost;213
1.17.9;Summary of Key Points;213
1.17.10;References;213
1.18;13: Endoscopic Drainage of Pancreatic Fluid Collections;218
1.18.1;Introduction;218
1.18.2;Diagnostic Work-up;219
1.18.3;Indications;219
1.18.4;Patient Preparation for Pseudocyst Drainage;220
1.18.5;Procedure;220
1.18.5.1;Transpapillary Pseudocyst Drainage;220
1.18.5.2;Transmural Pseudocyst Drainage;220
1.18.5.3;Cystoscopy-Guided Debridement;222
1.18.6;Post-procedural Care;224
1.18.7;Complications and Management;224
1.18.8;Alternative Procedures;224
1.18.9;Cost Effectiveness;225
1.18.10;References;225
1.19;14: Endoscopic Management of Pancreatic Pseudocysts;227
1.19.1;Introduction;227
1.19.2;Incidence and Etiology of Pseudocysts;227
1.19.3;Pathogenesis and Classification;228
1.19.4;Clinical Presentation and Diagnosis;231
1.19.4.1;History, Physical Examination, and Laboratory Evaluations: Narrowing the Differential;231
1.19.4.2;Imaging Studies and Possible Fluid Sampling;233
1.19.4.2.1;Conventional Abdominal Ultrasound;233
1.19.4.2.2;CT, MRI, and ERCP;233
1.19.4.2.3;EUS and Possible Fine Needle Aspiration with Fluid Analysis;234
1.19.5;Treatment of Pancreatic Pseudocysts;235
1.19.5.1;Preprocedural Assessment;235
1.19.5.2;Surgical Drainage;236
1.19.5.3;Percutaneous Drainage;237
1.19.5.4;Endoscopic Drainage;237
1.19.5.4.1;Efficacy and Cost-Effectiveness of Endoscopic Management;238
1.19.5.4.2;Technique of Cystgastrostomy/Duodenostomy;239
1.19.5.4.3;Transpapillary Drainage;241
1.19.5.4.4;Complications and Their Avoidance;242
1.19.6;References;244
1.20;15: EUS-Guided Drainage of Pelvic Abscesses;247
1.20.1;Introduction;247
1.20.2;Transvaginal/Transrectal Ultrasound-Guided Drainage;248
1.20.3;CT Guided Drainage;248
1.20.4;Surgery;248
1.20.5;Why Endoscopic Ultrasound Drainage?;249
1.20.6;Procedural Technique;249
1.20.7;Technical Outcomes;251
1.20.8;Limitations;252
1.20.9;References;252
1.21;16: Technique of Endoscopic Ultrasound-Guided Fine Needle Aspiration (EUS-FNA);254
1.21.1;Introduction;254
1.21.2;Indications;255
1.21.3;Contraindications;255
1.21.4;Pre-evaluation;255
1.21.5;Preparation;256
1.21.6;Position;256
1.21.7;Equipment;256
1.21.7.1;The Echoendoscope;256
1.21.7.2;Prior Radial EUS;257
1.21.7.3;The Needle;259
1.21.7.4;Suction Syringes;260
1.21.8;Technique;261
1.21.8.1;Identification/Selection of the Target Lesion;262
1.21.8.2;Alignment of the Lesion in the Projected Path of the Needle;264
1.21.8.3;Stabilizing the Transducer;264
1.21.8.4;Apposition of the Transducer;264
1.21.8.5;Color Doppler Evaluation;264
1.21.8.6;Needle Puncture;265
1.21.8.7;Sampling the Targeted Lesion with or without Suction;268
1.21.8.8;Withdrawal of the Needle;269
1.21.8.9;Transfer of the Sampled Tissue or Fluid for Cytopathology;269
1.21.9;Complications;270
1.21.9.1;Perforation;270
1.21.9.2;Acute Pancreatitis;275
1.21.9.3;Bleeding;275
1.21.9.4;Infection;276
1.21.10;References;276
1.22;17: The Role of Endoscopic Ultrasound in Pain Management;278
1.22.1;Introduction;278
1.22.2;Pathophysiology;278
1.22.3;EUS-Guided Celiac Plexus Block and Neurolysis;279
1.22.4;Techniques for Performing EUS-Guided CPN and CPB;280
1.22.5;Superior Hypogastric Plexus Neurolysis;286
1.22.6;Ganglion Impar Neurolysis;290
1.22.7;References;294
1.23;18: Colonoscopic Polypectomy;296
1.23.1;Introduction;296
1.23.2;Indications;297
1.23.3;Contraindications;298
1.23.4;Procedure Site;299
1.23.5;Procedure Description;300
1.23.6;Polyp Retrieval;303
1.23.7;Complications;306
1.23.8;Post-procedure Care;307
1.23.9;Results;308
1.23.10;Alternatives;308
1.23.11;Cost;308
1.23.12;References;309
1.24;19: Acute Colonic Bleeding;311
1.24.1;Introduction;311
1.24.2;Epidemiology;312
1.24.3;Resuscitation and Initial Evaluation;312
1.24.4;Approach to the Patient with Severe Hematochezia–Clinical Algorithm;314
1.24.5;Diagnostic Evaluations;314
1.24.6;Colonoscopy;315
1.24.7;Bowel Preparation;316
1.24.8;CURE Hemostasis Group Results with an Urgent Endoscopic Approach to Severe Hematochezia;317
1.24.9;Alternate Procedures;317
1.24.9.1;Traditional Management of Severe Hematochezia in Adults;317
1.24.9.2;Emergency Abdominal Angiography;319
1.24.9.3;Red Cell Scanning;320
1.24.9.4;Results of Traditional Approach to Severe Hematochezia;321
1.24.10;Specific Colonic Lesions;321
1.24.10.1;Diverticular Hemorrhage;321
1.24.10.2;Internal Hemorrhoids;323
1.24.10.3;Ischemic Colitis;324
1.24.10.4;Solitary Rectal Ulcer Syndrome;325
1.24.10.5;Delayed Post-polypectomy Hemorrhage;325
1.24.10.6;Colonic Angiomas;327
1.24.10.7;Cost Assessment;328
1.24.11;References;328
1.25;20: Complications and Their Risk Factors in Gastrointestinal Endoscopy;331
1.25.1;Introduction;331
1.25.2;Complications Related to Preparation for Endoscopy;332
1.25.2.1;Upper Endoscopy;332
1.25.2.2;Colonoscopy;332
1.25.3;Complications Related to Sedation and Anesthesia;333
1.25.4;Cardiovascular Complications;334
1.25.5;Infection;335
1.25.6;Perforation;336
1.25.6.1;Upper Endoscopy;336
1.25.6.2;Colonoscopy;337
1.25.7;Post-polypectomy Syndrome;337
1.25.8;Bleeding;338
1.25.8.1;Upper Endoscopy;338
1.25.8.2;Colonoscopy;338
1.25.9;Aspiration;338
1.25.10;Vasovagal Reactions;340
1.25.11;Splenic Injury;340
1.25.12;Entrapment of the Endoscope;340
1.25.13;Complications of Percutaneous Endoscopic Gastrostomy;340
1.25.13.1;Fistula;340
1.25.13.2;Buried Bumper Syndrome;341
1.25.13.3;Stoma Leak or Enlargement;341
1.25.13.4;Wound/Tube Infection;341
1.25.13.5;Tube Dislodgement;342
1.25.13.6;Pneumoperitoneum;342
1.25.13.7;Hemorrhage;342
1.25.14;Endoscopic Retrograde Cholangiopancreatography;342
1.25.14.1;Pancreatitis;342
1.25.14.2;Infection;343
1.25.14.3;Hemorrhage;343
1.25.14.4;Perforation;344
1.25.14.5;Cardiopulmonary Complications;344
1.25.14.6;Mortality;344
1.25.14.7;Miscellaneous Complications;344
1.25.15;Endoscopic Ultrasound;344
1.25.15.1;Perforation;345
1.25.15.2;Bleeding;345
1.25.15.3;Infection;345
1.25.15.4;Pancreatitis;345
1.25.15.5;Miscellaneous;346
1.25.16;Advanced Therapeutic Techniques;346
1.25.16.1;Endoscopic Mucosal Resection;346
1.25.16.2;Radiofrequency Ablation;346
1.25.17;Endoscopy in Pregnant or Lactating Women;347
1.25.18;References;348
1.26;21: Documentation and Description of Endoscopic Procedures;351
1.26.1;Introduction;351
1.26.2;Photodocumentation of Endoscopic Procedures;352
1.26.3;Upper Gastrointestinal Endoscopy;352
1.26.4;Colonoscopy;357
1.26.5;Accurate Description of Endoscopic Findings;362
1.26.6;Terminology;363
1.26.7;Location of the Lesion;363
1.26.8;Description of Lesions;363
1.26.9;References;366
1.27;22: Ultrasound-Guided/Assisted Percutaneous Liver Biopsy;367
1.27.1;Introduction;367
1.27.2;Indications;368
1.27.3;Contraindications;369
1.27.4;Procedure Technique: Percutaneous Ultrasound-Assisted Liver Biopsy;370
1.27.5;Biopsy with a Jamshidi-Menghini Needle Kit;370
1.27.6;Alternate Devices;375
1.27.7;Liver Biopsy Gun;376
1.27.8;Complications;376
1.27.9;Costs;377
1.27.10;References;378
1.28;Index;379




